WEC
ELV icon

Winslow Evans & Crocker’s Elevance Health ELV Stock Holding History

Winslow Evans & Crocker’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$608K Buy
1,896
+64
+3% +$19.6K 0.12% 182
2020
Q3 		$492K Buy
1,832
+231
+14% +$62.2K 0.12% 164
2020
Q2 		$421K Buy
1,601
+617
+63% +$165K 0.11% 175
2020
Q1 		$226K Buy
984
+160
+19% +$43.6K 0.07% 223
2019
Q4 		$250K Buy
824
+56
+7% +$15.4K 0.06% 253
2019
Q3 		$186K Sell
768
-260
-25% -$71.2K 0.05% 289
2019
Q2 		$292K Sell
1,028
-954
-48% -$261K 0.08% 241
2019
Q1 		$570K Sell
1,982
-12
-0.6% -$3.47K 0.16% 143
2018
Q4 		$526K Buy
1,994
+594
+42% +$163K 0.18% 129
2018
Q3 		$384K Buy
1,400
+1,124
+407% +$292K 0.12% 182
2018
Q2 		$66K Hold
276
– – 0.02% 444
2018
Q1 		$60.2K Sell
276
-14
-5% -$3.29K 0.02% 448
2017
Q4 		$65K Sell
290
-70
-19% -$14.9K 0.02% 440
2017
Q3 		$68.2K Buy
360
+1
+0.3% +$190 0.02% 418
2017
Q2 		$67.5K Sell
359
-1
-0.3% -$180 0.02% 497
2017
Q1 		$59.4K Hold
360
– – 0.02% 503
2016
Q4 		$51.6K Hold
360
– – 0.02% 528
2016
Q3 		$45K Hold
360
– – 0.01% 563
2016
Q2 		$47.2K Buy
360
+251
+230% +$34.3K 0.01% 526
2016
Q1 		$15.2K Sell
109
-103
-49% -$13.8K ﹤0.01% 773
2015
Q4 		$29.2K Buy
212
+2
+1% +$276 0.01% 654
2015
Q3 		$29.3K Sell
210
-4,476
-96% -$673K 0.01% 625
2015
Q2 		$769K Sell
4,686
-38
-0.8% -$6.07K 0.22% 110
2015
Q1 		$729K Buy
4,724
+4,476
+1,805% +$637K 0.21% 109
2014
Q4 		$31K Buy
248
+38
+18% +$4.7K 0.01% 636
2014
Q3 		$25K Buy
210
+1
+0.5% +$115 0.01% 689
2014
Q2 		$22.5K Hold
209
– – 0.01% 649
2014
Q1 		$20.8K Hold
209
– – 0.01% 662
2013
Q4 		$19K Buy
+209
New +$18.6K 0.01% 712

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Winslow Evans & Crocker's ELV Position: Q4 2020 in Review

Winslow Evans & Crocker increased its Elevance Health (ELV) stake by 3.5% in Q4 2020, buying an estimated $19.6K and bringing the position to 1,896 shares worth $608K. The position accounts for 0.12% of the portfolio, ranked #182.

Winslow Evans & Crocker first reported a position in ELV in Q4 2013 and has held it in 29 quarters since. The position peaked at $769K in Q2 2015. 1,170 funds tracked by Wall St. Rank hold ELV as of Q4 2020.

  • Winslow Evans & Crocker held 1,896 shares of Elevance Health worth $608K as of Q4 2020.
  • Winslow Evans & Crocker bought 64 Elevance Health shares in Q4 2020, an estimated $19.6K.
  • Elevance Health made up 0.12% of Winslow Evans & Crocker's portfolio in Q4 2020, its #182 holding.
  • Winslow Evans & Crocker first reported a position in Elevance Health in Q4 2013 and has held it in 29 quarters since.
  • Winslow Evans & Crocker's Elevance Health position peaked at $769K in Q2 2015.
  • 1,170 funds tracked by Wall St. Rank held Elevance Health as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.